Shares of HemaCare Co. (OTCMKTS:HEMA – Get Free Report) traded up 0.6% during mid-day trading on Thursday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6 %
The firm’s 50 day moving average is $25.31 and its 200-day moving average is $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- MarketBeat Week in Review – 4/22 – 4/26
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Stocks Leading the U.S. Agriculture Comeback
- Insider Selling Explained: Can it Inform Your Investing Choices?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
